ANDA 218687, held by Novitium Pharma. Esomeprazole Magnesium.
As of Nov 16, 2026, ANDA 218687 (Esomeprazole Magnesium), held by Novitium Pharma, was first approved by FDA on Sep 25, 2026, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Sep 25, 2026 | Original application | Approved | None posted |
| Esomeprazole MagnesiumEQ 20MG BASE/PACKET · for suspension, delayed release;oral | Esomeprazole Magnesium | Rx |
| Esomeprazole MagnesiumEQ 40MG BASE/PACKET · for suspension, delayed release;oral | Esomeprazole Magnesium | Rx |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters